AXNX / Axonics: A Strong Medical Device Play With Significant Revenue Growth Opportunities

Axonics, Inc. (NASDAQ:AXNX ) Q3 2023 Earnings Conference Call October 30, 2023 4:30 PM ET Company Participants Neil Bhalodkar - Vice President of Inve more_horizontal

Axonics Modulation Technologies (AXNX) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.05 pe more_horizontal

Axonics is a medical device company that focuses on bladder and bowel dysfunction therapies. The company also upgraded its annual revenue guidance. more_horizontal

Axonics, Inc. (NASDAQ:AXNX ) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ET Company Participants Neil Bhalodkar - Vice President of Investo more_horizontal

Axonics Modulation Technologies (AXNX) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.12. This more_horizontal

Axonics, Inc. (NASDAQ:AXNX ) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Neil Bhalodkar - VP of IR Raymond Cohen - CE more_horizontal

Axonics Modulation Technologies (AXNX) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.34. This more_horizontal

Axonics, Inc. (NASDAQ:AXNX ) Q4 2022 Earnings Conference Call March 1, 2023 4:30 PM ET Company Participants Neil Bhalodkar - VP of IR Raymond Cohen - more_horizontal